Navigation Links
Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery

eeding rates were 0.6% and 0.5%, and any bleeding rates were 4.9% and 4.8%, respectively. The RECORD3 trial demonstrated superior efficacy of rivaroxaban versus enoxaparin, with similarly low bleeding rates, in patients undergoing TKR.

Head of Global Development Dr. Kemal Malik, a member of Bayer HealthCare Executive Committee and management board member of Bayer Schering Pharma, commented: "Based on the data we have generated, rivaroxaban shows great promise that it could set a new standard of care in thromboembolic disease as a new benchmark for balancing safety and efficacy in anticoagulation. We hope that the clinical trials will continue to demonstrate the compelling efficacy and safety profile for rivaroxaban, while also demonstrating its utility in both the hospital and home settings without the need for routine monitoring."

The trade name of rivaroxaban is expected to be Xarelto®, pending health authority approval.

Additional Phase III results of the ongoing RECORD program are expected to be available during H2 2007.

Unmet Needs in Venous Thromboembolism (VTE) VTE is a type of thromboembolic disease that affects approximately 6.5 million people worldwide annually. Thromboembolic disease, which is caused by the obstruction of a blood vessel by a blood clot, is a leading cause of global mortality and a concern for many patient populations, including those with atrial fibrillation at risk for stroke; those at risk for acute myocardial infarction (heart attack); those undergoing orthopaedic surgery at risk for developing DVT and PE; and hospitalized, medically ill patients immobilized by cancer, congestive heart failure, acute respiratory disease, or other illnesses.

About Rivaroxaban (Xarelto®) Phase IIb data - presented at ISTH in 2005, and published in the Journal of Thrombosis and Haemostasis in 2005 and 2006, and the additional once-daily ODIXa HIP study published in Circulation in 2006 - indicate that rivaroxaban
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
(Date:8/28/2015)... DRAPER, Utah , Aug. 28, 2015  Today, ... and Prevention,s (CDC) Contact Lens Health Week, 1-800 Contacts ... CDC has found that contact lens wearers who do ... the greatest risk for eye infections. ... cleaning their lenses, but a clean lens case is ...
(Date:8/28/2015)... -- Research and Markets ( ... "Investigation Report on China,s Quetiapine Market, 2010-2019" ... by AstraZeneca plc, quetiapine (under the trade name ... treatment of schizophrenia. Approved by CFDA to treat ... Catalogue of Drugs for the Basic National Medical ...
(Date:8/28/2015)... Aug. 28, 2015 ... the addition of the "Investigation Report on ... offering. Developed by Pharmacia & Upjohn ... agonist which effectively reduces intraocular pressure. As the ... (under the trade name of Xalatan) entered ...
Breaking Medicine Technology:1-800 Contacts Shares Tips on How to Clean Lens Cases 2China Quetiapine Market Investigation Report 2010-2019 2China Latanoprost Market Investigation Report 2015-2019 2
... 10, 2007 - According to,The Waismann Method ... respondents seeking treatment for opiate dependency have ... OxyContin, Percocet,and Fentanyl were among the drugs ... who reported a dependency said they suffered ...
... a German biopharmaceutical company specialized in targeted,therapies for ... IIb-study with AP 12009 in high-grade glioma will ... American Society of,Clinical Oncology (ASCO), which will be ... 5th. , In the open-label, randomized dose-finding Phase,IIb-trial ...
Cached Medicine Technology:Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate,Dependency Treatment Are Mothers 22007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with,AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion 22007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with,AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion 3
(Date:8/31/2015)... Knoxville, TN (PRWEB) , ... August 31, 2015 ... ... of urgent care and accessible primary care, is enhancing its existing presence in ... Pike in Knoxville. The location is the company’s second in Knoxville, sixteenth in ...
(Date:8/31/2015)... ... August 31, 2015 , ... Kognito , a leader ... competencies in managing challenging conversations, announced today that Glenn Albright, Ph.D., the company’s ... Excellence for Psychological Health and Traumatic Brain Injury (DCoE) Summit taking place ...
(Date:8/31/2015)... ... August 31, 2015 , ... In preparation for this ... maker of the BEAN™ personal sound amplifier, is offering caregivers “7 Reasons to Care ... a way of coping with a variety of home healthcare challenges, specifically as they ...
(Date:8/31/2015)... Nashville, Tennessee (PRWEB) , ... ... ... College of Lifestyle Medicine (ACLM), the nation’s medical professional association for physicians ... option, in conjunction with the Lifestyle Medicine Foundation, announced today the establishment ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... nonprofit authority on the use of health IT to create efficiencies in healthcare ... WEDI-Con 2015 . Taking place at the Hyatt Regency Reston in Reston, ...
Breaking Medicine News(10 mins):Health News:State-of-the-Art Urgent Care Facility Opening in Knoxville 2Health News:Kognito’s Glenn Albright to Present at DCoE Summit 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 3Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 2Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 3Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 2Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 3
... The first complete update in five years of ... opportunistic infections has been released by the National ... Control and Prevention in cooperation with the HIV ... America (IDSA). , The new Guidelines for ...
... April 16 Elsevier and the,American ... JACC: Cardiovascular,Imaging ( http://www.elsevier.com/locate/jacima ) (ISSN: ... ) (ISSN:,1936-8798) have been selected for ... U.S.,National Library of Medicine(R), MEDLINE (Medical ...
... Deerfield Spa, the affordable and friendly destination ... the opening of the Deerfield Day Spa program, ... first time, to day spa guests.Deerfield,s Day Spa ... spa services, such as massage, facials, body treatments, ...
... who suffer from migraines avoid taking aerobic exercise because ... on a serious migraine attack. Researchers at the Sahlgrenska ... exercise programme that can improve fitness among migraine sufferers ... from migraines are often advised to take exercise, but ...
... Ontario Systems, LLC, a provider of revenue cycle management ... care and debt management industries, today announces a multi-year ... premier cancer center. MSKCC has purchased Ontario Systems, ... powerful new tools to follow up on third-party claims ...
... April 16 Tigris Pharmaceuticals, Inc., a privately ... announced the appointment of Pedro Granadillo as Chairman ... Granadillo is a highly-respected pharmaceutical industry leader with ... "Pedro,s appointment as Chairman of the Board of ...
Cached Medicine News:Health News:US releases updated clinical guidelines for HIV-associated opportunistic infections 2Health News:US releases updated clinical guidelines for HIV-associated opportunistic infections 3Health News:JACC: Cardiovascular Imaging and JACC: Cardiovascular Interventions Accepted for Coverage In MEDLINE(R) 2Health News:JACC: Cardiovascular Imaging and JACC: Cardiovascular Interventions Accepted for Coverage In MEDLINE(R) 3Health News:Deerfield Spa, the Northeast's Most Affordable Destination Spa, Now Offers Day Spa Getaways 2Health News:Safe exercise for migraine sufferers 2Health News:Ontario Systems Signs Multi-Year Agreement with Memorial Sloan-Kettering Cancer Center 2Health News:Tigris Pharmaceuticals Appoints Pedro Granadillo as Chairman of Board of Directors 2Health News:Tigris Pharmaceuticals Appoints Pedro Granadillo as Chairman of Board of Directors 3
Flag shaped sharp tip. Flat serrated handle with polished finish....
For use with E0828 A needle tip and E0828 B gouge tip. Round knurled with threaded ended for tips. Most popular size or model....
Threaded ends permit guarding the needle and gouge within the handle. Set consists of one each : E0828 A needle tip, E0828 B gauge tip and E0828 C handle. Most popular size or model....
Battery operated single speed motorized handpiece, tip cover, supplied with 0.5 mm tungsten burr (E0815 0.5) and one battery size "AA"....
Medicine Products: